Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001628280-23-039321

Chief Medical Officer returned 2,098 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Podnos Yale Chief Medical Officer 2023-11-14 Returned to the company −238 $2.39 $568 90,228 D
Podnos Yale Chief Medical Officer 2023-11-14 Returned to the company −1,860 $2.39 $4,436 88,368 D
Loading xslF345X05/wk-form4_1700170789.xml…